Cellbox Solutions
Private Company
Total funding raised: $5M
Overview
Founded in 2019 and based in Berlin, Cellbox Solutions addresses a critical bottleneck in the cell therapy and life sciences sectors: the reliable, live shipment of delicate biological materials. The company's core offering is the Cellbox™, a portable, battery-powered CO2 incubator, which it combines with managed logistics services to ensure cells remain in an optimal physiological environment from lab to clinic. By enabling 'warm chain' logistics, Cellbox aims to reduce cell loss during transport, improve the quality of delivered cell-based products, and support the advancement of cryo-sensitive therapies. Its technology is validated by research institutions and biotech companies for shipping a range of materials, including immune cells, iPSCs, and 3D tissue models.
Technology Platform
Portable, active CO2 and temperature-controlled incubators (CELLBOX™ GO & SHIPPER) combined with managed logistics services to enable 'Warm Chain' transport of live cells, tissues, and cell-based therapies.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Cellbox operates in a specialized niche with limited direct competitors offering integrated active-control portable incubators and services. Competition likely comes from traditional cryopreservation/logistics providers (e.g., Cryoport, Marken), passive thermal shipper companies, and potential new entrants from the medical incubator or general logistics sectors seeking to address the biotransport opportunity.